跳至主要内容
临床试验/JPRN-UMIN000011893
JPRN-UMIN000011893尚未招募未知

Efficacy of therapeutic drug monitoring of mTOR inhibitor (Everolimus) in patients with renal cell carcinoma - Efficacy of therapeutic drug monitoring of mTOR inhibitor (Everolimus) in patients with renal cell carcinoma

Osaka General Medical Center0 个研究点目标入组 20 人开始时间: 2013年9月28日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients in contraindication 2. Patients with hepatic function disorder 3. Patients diagnosed as interstitial pneumonia 4. Patients who have already treated with Everolimus 5. Patients who are judged as inadequate by doctor in attendance

研究者

相似试验